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RGD (arginine-glycine-aspartic acid) peptides have shown some promising abilities to 
promote the attachment of cells to biomaterials and to direct their differentiation. 
However, anchoring these peptides to the biomaterial’s surface is mandatory and 
usually implies several chemical linking steps. The aim of this work was to design and 
characterize a synthetic RGD biomimetic peptide that includes a collagen-binding 
domain for easy one-step functionalization of absorbable collagen sponges (ACSs), 
which are of frequent use in orthopaedic surgery. 
The stable binding of biotinylated CBD-RGD peptide loaded onto ACSs was confirmed 
using chemiluminisence detection after washing of the sponges. Furthermore, the effect 
of the peptide on MC3T3-E1 mouse preosteoblasts and rat bone marrow-derived 
mesenchymal stem cells (MSCs) in vitro was characterized in terms of caspase activity, 
proliferation, alkaline phosphatase (ALP) activity, matrix mineralization and formation 
of focal adhesions. Finally, a rat ectopic osteogenesis model was used to determine if 
the co-administration of CBD-RGD could lower the dose of BMP-2 necessary to induce 
bone formation. 
The CBD-RGD peptide was demonstrated to bind stable to ACSs, even after extensive 
washing. In vitro, the peptide did not induce apoptosis of the cells, but positively 
affected both cell growth and differentiation. It also seemed to affect the cytoskeleton 
arrangement of MC3T3-E1 cells, favoring the establishment of focal adhesions. At last, 
the in vivo experiments showed that ACSs functionalized with this peptide and loaded 
with a subfunctional dose of BMP-2 gave rise to ectopic bone. 
In conclusion. the combination of CBD-RGD with the currently used collagen/BMP 
system might be a promising approach to improve osteogenesis and to reduce the doses 
of BMPs needed in clinical orthopaedics. 
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